PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF JP-1366, A NOVEL POTASSIUM-COMPETITIVE ACID BLOCKER, AFTER A SINGLE ORAL DOSE IN HEALTHY SUBJECTS.

被引：0
|
作者：
Kim, J. [1 ,2 ]
Jin, X. [1 ]
Hwang, I. [1 ]
Oh, J. [1 ]
Kim, J. [1 ,2 ]
Park, J. [2 ]
Heo, J. [3 ]
Lee, Y. [3 ]
Jang, I. -J. [1 ]
Chung, J. -Y. [1 ,4 ]
Lee, S. [1 ]
机构：
[1] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med, Seoul, South Korea
[2] JEIL Pharmaceut Co Ltd, R&D Ctr, Yongin, South Korea
[3] JEIL Pharmaceut Co Ltd, Dev Dept, Seoul, South Korea
[4] Bundang Hosp, Seongnam, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-068
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS, PHARMACODYNAMICS AND SAFETY OF MULTIPLE ORAL DOSES OF JP-1366, A POTASSIUM-COMPETITIVE ACID BLOCKER, IN HEALTHY SUBJECTS.
    Park, Y.
    Yang, E.
    Jeong, S.
    Choe, K.
    Park, J.
    Oh, J.
    Yoon, S.
    Jang, I.
    Lee, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S29 - S29
  • [2] Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects
    Hwang, Inyoung
    Ji, Sang Chun
    Oh, Jaeseong
    Kim, Hyojin
    Cha, Hyunju
    Kim, John
    Lee, Chang-Seok
    Yu, Kyung-Sang
    Lee, SeungHwan
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (07) : 763 - 772
  • [3] Keverprazan, a novel potassium-competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects
    Zhou, Sufeng
    Xie, Lijun
    Zhou, Chen
    Wang, Lu
    Chen, Juan
    Ding, Sijia
    Zhu, Bei
    Su, Mei
    Shao, Feng
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 1911 - 1922
  • [4] Population pharmacokinetic analysis of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in patients and healthy volunteers
    Yang, Eunsol
    Hwang, Inyoung
    Ji, Sang Chun
    Kim, John
    Lee, SeungHwan
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024,
  • [5] Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
    Zhou, Sufeng
    Xie, Lijun
    Zhou, Chen
    Zhao, Yuqing
    Wang, Lu
    Ding, Sijia
    Chen, Juan
    Zhu, Bei
    Su, Mei
    Shao, Feng
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 190
  • [6] JP-1366: A novel and potent potassium-competitive acid blocker that is effective in the treatment of acid-related diseases
    Ku, Jin Mo
    Cho, Jin Hee
    Kim, Kangjeon
    Kim, Ji Yoon
    Kim, Jong Yup
    Kim, John
    Cha, Hyunju
    Cheon, Banyoon
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (03): : e01090
  • [7] Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects
    Sunwoo, J.
    Oh, J.
    Moon, S. J.
    Ji, S. C.
    Lee, S. H.
    Yu, K. -S.
    Kim, H. S.
    Lee, A.
    Jang, I. -J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (02) : 206 - 218
  • [8] Pharmacokinetics and pharmacodynamics of intravenous and oral fexuprazan, a potassium-competitive acid blocker, after single administration in healthy Korean and Chinese
    Park, J.
    Jeong, S.
    Kim, B.
    Cho, J.
    Lee, S.
    Lee, A.
    Jang, I
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S25 - S26
  • [9] Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ-12420), a novel potassium-competitive acid blocker, in healthy male subjects
    Han, Sungpil
    Choi, Hee Youn
    Kim, Yo Han
    Nam, Ji Yeon
    Kim, Bongtae
    Song, Geun Seog
    Lim, Hyeong-Seok
    Bae, Kyun-Seop
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (07) : 751 - 759
  • [10] PHARMACODYNAMICS AND PHARMACOKINETICS OF THE POTASSIUM-COMPETITIVE ACID BLOCKER VONOPRAZAN AND THE PROTON PUMP INHIBITOR LANSOPRAZOLE IN HEALTHY US SUBJECTS
    Laine, Loren
    Sharma, Prateek
    Mulford, Darcy J.
    Hunt, Barbara
    Leifke, Eckhard
    Smith, Neila
    Howden, Colin W.
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S543 - S544
12345